Molina T - Search Results

1

Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.

Fergelot P, Molina T, Blanchet P, Grimber G, Duquenne O, Couton D, Zider A, Briand P, Cavard C. Fergelot P, et al. Among authors: molina t. C R Acad Sci III. 1995 Mar;318(3):329-37. C R Acad Sci III. 1995. PMID: 7788501

2

Compensatory apoptosis in response to SV40 large T antigen expression in the liver.

Allemand I, Grimber G, Kornprobst M, Bennoun M, Molina T, Briand P, Joulin V. Allemand I, et al. Among authors: molina t. Oncogene. 1995 Dec 21;11(12):2583-90. Oncogene. 1995. PMID: 8545115

3

Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G, Briand P, Vainchenker W, Tavitian A. Moreau-Gachelin F, et al. Among authors: molina t. Mol Cell Biol. 1996 May;16(5):2453-63. doi: 10.1128/MCB.16.5.2453. Mol Cell Biol. 1996. PMID: 8628313 Free PMC article.

4

The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.

Bennoun M, Grimber G, Couton D, Seye A, Molina T, Briand P, Joulin V. Bennoun M, et al. Among authors: molina t. Oncogene. 1998 Sep 10;17(10):1253-9. doi: 10.1038/sj.onc.1202047. Oncogene. 1998. PMID: 9771968

5

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.

Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, Buendia MA. Terradillos O, et al. Among authors: molina t. Oncogene. 1997 Jan 30;14(4):395-404. doi: 10.1038/sj.onc.1200850. Oncogene. 1997. PMID: 9053836

6

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.

Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet-Monsac M, Abelanet R, Briand P. Dubois N, et al. Among authors: molina t. J Hepatol. 1991 Sep;13(2):227-39. doi: 10.1016/0168-8278(91)90819-w. J Hepatol. 1991. PMID: 1660504

7

Effect of oxysterol derivatives on the time course development of hepatocarcinoma in transgenic mice.

Allemand I, Christ M, Pannecoucke X, Molina T, Luu B, Briand P. Allemand I, et al. Among authors: molina t. Anticancer Res. 1993 Jul-Aug;13(4):1097-101. Anticancer Res. 1993. PMID: 8394669

8

Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.

Rouquet N, Allemand I, Grimber G, Molina T, Briand P, Joulin V. Rouquet N, et al. Among authors: molina t. Cell Death Differ. 1996 Jan;3(1):91-6. Cell Death Differ. 1996. PMID: 17180059

9

[Transgenic mice, animal models of human diseases].

Molina T, Allemand I, Bigorgne C, Audouin J, Briand P, Diebold J. Molina T, et al. Ann Pathol. 1995;15(3):168-77. Ann Pathol. 1995. PMID: 7639852 Review. French. No abstract available.

10

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Morel A, de La Coste A, Fernandez N, Berson A, Kaybanda M, Molina T, Briand P, Haddada H, Guillet JG, Antoine B, Viguier M, Kahn A. Morel A, et al. Among authors: molina t. Cancer Gene Ther. 1998 Mar-Apr;5(2):92-100. Cancer Gene Ther. 1998. PMID: 9570300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters